Formation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol

Benjamin Hinrichs, Muhammad Zahid, Muhammad Saeed, Mohammed F. Ali, Ercole Cavalieri, Eleanor G Rogan

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Extensive evidence exists that the reaction of estrogen metabolites with DNA produces depurinating adducts that, in turn, induce mutations and cellular transformation. While it is clear that these estrogen metabolites result in a neoplastic phenotype in vitro, further evidence supporting the link between estrogen-DNA adduct formation and its role in neoplasia induction in vivo would strengthen the evidence for a genotoxic mechanism. Diethylstilbestrol (DES), an estrogen analogue known to increase the risk of breast cancer in women exposed in utero, is hypothesized to induce neoplasia through a similar genotoxic mechanism. Cultured MCF-10F human breast epithelial cells were treated with DES at varying concentrations and for various times to determine whether the addition of DES to MCF-10F cells resulted in the formation of depurinating adducts. This is the first demonstration of the formation of DES-DNA adducts in human breast cells. A dose-dependent increase in DES-DNA adducts was observed. Demonstrating that treatment of MCF-10F cells with DES, a known human carcinogen, yields depurinating adducts provides further support for the involvement of these adducts in the induction of breast neoplasia. Previous studies have demonstrated the ability of antioxidants such as resveratrol to prevent the formation of estrogen-DNA adducts, thus preventing a key carcinogenic event. In this study, when MCF-10F cells were treated with a combination of resveratrol and DES, a dose-dependent reduction in the level of DES-DNA adducts was also observed.

Original languageEnglish (US)
Pages (from-to)276-281
Number of pages6
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume127
Issue number3-5
DOIs
StatePublished - Nov 1 2011

Fingerprint

Diethylstilbestrol
DNA Adducts
Breast
Epithelial Cells
Estrogens
Metabolites
Estradiol Congeners
Neoplasms
resveratrol
Carcinogens
Demonstrations
Antioxidants
Breast Neoplasms
Phenotype
Mutation
DNA

Keywords

  • Catechol estrogen quinones
  • DES-DNA adducts
  • MCF-10F cells
  • Resveratrol

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Formation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol. / Hinrichs, Benjamin; Zahid, Muhammad; Saeed, Muhammad; Ali, Mohammed F.; Cavalieri, Ercole; Rogan, Eleanor G.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 127, No. 3-5, 01.11.2011, p. 276-281.

Research output: Contribution to journalArticle

@article{70a43dd65c9044f58b837a463fce10c7,
title = "Formation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol",
abstract = "Extensive evidence exists that the reaction of estrogen metabolites with DNA produces depurinating adducts that, in turn, induce mutations and cellular transformation. While it is clear that these estrogen metabolites result in a neoplastic phenotype in vitro, further evidence supporting the link between estrogen-DNA adduct formation and its role in neoplasia induction in vivo would strengthen the evidence for a genotoxic mechanism. Diethylstilbestrol (DES), an estrogen analogue known to increase the risk of breast cancer in women exposed in utero, is hypothesized to induce neoplasia through a similar genotoxic mechanism. Cultured MCF-10F human breast epithelial cells were treated with DES at varying concentrations and for various times to determine whether the addition of DES to MCF-10F cells resulted in the formation of depurinating adducts. This is the first demonstration of the formation of DES-DNA adducts in human breast cells. A dose-dependent increase in DES-DNA adducts was observed. Demonstrating that treatment of MCF-10F cells with DES, a known human carcinogen, yields depurinating adducts provides further support for the involvement of these adducts in the induction of breast neoplasia. Previous studies have demonstrated the ability of antioxidants such as resveratrol to prevent the formation of estrogen-DNA adducts, thus preventing a key carcinogenic event. In this study, when MCF-10F cells were treated with a combination of resveratrol and DES, a dose-dependent reduction in the level of DES-DNA adducts was also observed.",
keywords = "Catechol estrogen quinones, DES-DNA adducts, MCF-10F cells, Resveratrol",
author = "Benjamin Hinrichs and Muhammad Zahid and Muhammad Saeed and Ali, {Mohammed F.} and Ercole Cavalieri and Rogan, {Eleanor G}",
year = "2011",
month = "11",
day = "1",
doi = "10.1016/j.jsbmb.2011.08.009",
language = "English (US)",
volume = "127",
pages = "276--281",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "3-5",

}

TY - JOUR

T1 - Formation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol

AU - Hinrichs, Benjamin

AU - Zahid, Muhammad

AU - Saeed, Muhammad

AU - Ali, Mohammed F.

AU - Cavalieri, Ercole

AU - Rogan, Eleanor G

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Extensive evidence exists that the reaction of estrogen metabolites with DNA produces depurinating adducts that, in turn, induce mutations and cellular transformation. While it is clear that these estrogen metabolites result in a neoplastic phenotype in vitro, further evidence supporting the link between estrogen-DNA adduct formation and its role in neoplasia induction in vivo would strengthen the evidence for a genotoxic mechanism. Diethylstilbestrol (DES), an estrogen analogue known to increase the risk of breast cancer in women exposed in utero, is hypothesized to induce neoplasia through a similar genotoxic mechanism. Cultured MCF-10F human breast epithelial cells were treated with DES at varying concentrations and for various times to determine whether the addition of DES to MCF-10F cells resulted in the formation of depurinating adducts. This is the first demonstration of the formation of DES-DNA adducts in human breast cells. A dose-dependent increase in DES-DNA adducts was observed. Demonstrating that treatment of MCF-10F cells with DES, a known human carcinogen, yields depurinating adducts provides further support for the involvement of these adducts in the induction of breast neoplasia. Previous studies have demonstrated the ability of antioxidants such as resveratrol to prevent the formation of estrogen-DNA adducts, thus preventing a key carcinogenic event. In this study, when MCF-10F cells were treated with a combination of resveratrol and DES, a dose-dependent reduction in the level of DES-DNA adducts was also observed.

AB - Extensive evidence exists that the reaction of estrogen metabolites with DNA produces depurinating adducts that, in turn, induce mutations and cellular transformation. While it is clear that these estrogen metabolites result in a neoplastic phenotype in vitro, further evidence supporting the link between estrogen-DNA adduct formation and its role in neoplasia induction in vivo would strengthen the evidence for a genotoxic mechanism. Diethylstilbestrol (DES), an estrogen analogue known to increase the risk of breast cancer in women exposed in utero, is hypothesized to induce neoplasia through a similar genotoxic mechanism. Cultured MCF-10F human breast epithelial cells were treated with DES at varying concentrations and for various times to determine whether the addition of DES to MCF-10F cells resulted in the formation of depurinating adducts. This is the first demonstration of the formation of DES-DNA adducts in human breast cells. A dose-dependent increase in DES-DNA adducts was observed. Demonstrating that treatment of MCF-10F cells with DES, a known human carcinogen, yields depurinating adducts provides further support for the involvement of these adducts in the induction of breast neoplasia. Previous studies have demonstrated the ability of antioxidants such as resveratrol to prevent the formation of estrogen-DNA adducts, thus preventing a key carcinogenic event. In this study, when MCF-10F cells were treated with a combination of resveratrol and DES, a dose-dependent reduction in the level of DES-DNA adducts was also observed.

KW - Catechol estrogen quinones

KW - DES-DNA adducts

KW - MCF-10F cells

KW - Resveratrol

UR - http://www.scopus.com/inward/record.url?scp=81255207082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255207082&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2011.08.009

DO - 10.1016/j.jsbmb.2011.08.009

M3 - Article

C2 - 21896331

AN - SCOPUS:81255207082

VL - 127

SP - 276

EP - 281

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 3-5

ER -